Trial · NCT06810882
Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy
NCT06810882, Not applicable, Recruiting, Tanta University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy. Trials, record NCT06810882. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06810882
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy
- NCT number
- NCT06810882
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 482 participants, estimated
- Lead sponsor
- Tanta University
- Conditions
- Ondansetron, Laparoscopic, Gastrectomy
- Interventions
- Perineural ondansetron, Intravenous ondansetron
- First posted
- 2025-02-06
- Last updated
- 2026-05-15
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of vomiting in the early 8 hours after surgery. | 8 hours after surgery. | Any attack of vomiting will be recorded for all patients. |
| Primary | Degree of postoperative pain at 1 hour after surgery as measured by the numerical rating scale pain score. | 1 hour after surgery. | Numerical rating scale pain score (NRS) ranges from 0 = no pain to 10= worst pain. |
| Secondary | Incidence of postoperative nausea and vomiting at 1 h, 8 h, and at 24 hours after surgery. | 24 hours after surgery. | Any attack of nausea and vomiting will be recorded for all patients. Numerical rating scale from 0 (no nausea) to 10 (worst nausea) will be used to assess the severity of nausea. |
| Secondary | Number of rescue anti-emetic doses in the first postoperative day. | 24 hours after surgery. | Routine anti-emetics will be given every 8 hours in the form of IV metoclopramide 10 mg. Rescue anti-emetic medication in the form of ondansetron 8 mg slowly IV will be given. The total required dose and number of ondansetron boluses will be recorded. |
| Secondary | Postoperative pain scores at 4 h, 8 h, and 24 hour after surgery. | 24 hours after surgery. | Numerical rating scale pain score (NRS) ranges from 0 = no pain to 10= worst pain will be used to evaluate pain scores after surgery. |
| Secondary | Time to first rescue opioid analgesic. | 24 hours after surgery. | opioid dose will be given to patients with pain score ≥ 4. |
| Secondary | Total opioid dose in the first day after surgery. | 24 hours after surgery. | opioid dose will be given to patients with pain score ≥ 4. |
| Secondary | Patient satisfaction | 24 hours after surgery. | Likert-type scale of 0-5 points will assess satisfaction before discharge from the hospital . |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06810882
GET https://conductscience.org/api/trials/v1/NCT06810882/registered